Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCNK10 antisense RNA 1 (KCNK10-AS1, also called AL133279.1) is a long non-coding RNA gene located in the human genome and transcribed antisense to the KCNK10 locus[4][5][7][9]. As with other lncRNAs, its primary presumed function is the regulation of gene expression, typically by sequence complementarity to the corresponding sense transcript, potentially influencing mRNA stability or chromatin remodeling. There is currently no evidence that this gene encodes a receptor, ion channel, enzyme, or that it is directly implicated as a therapeutic target[4][5][9]. Function-specific or disease-specific associations for KCNK10-AS1 have not been published in peer-reviewed literature or annotated in leading biological databases as of September 2025.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KCNK10 antisense RNA 1 (KCNK10-AS1).